FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

The ability to make patient-specific products quickly fits with the needs of smaller, resource-limited developers.

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

Barcelona’s blood and tissue bank says it has developed a new system for the large-scale production of mesenchymal stromal ...

Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines.

For some trees, wasted bark is a potential treasure-trove of biopharmaceuticals—from anti-inflammatories to cancer-fighting ...

QurAlis’ new headquarters offers enhanced lab and discovery resources and a 5,000-sq-ft conferencing space for meeting and ...

MICB and NOTCH4 were expressed in fibroblasts and endothelial cells, two cell types that play central roles in fibrosis and vasculopathy.

Researchers say using physically patterned surfaces applied to existing device materials would reduce barriers to commercial application.

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

By designing proteins de novo scientists can more efficiently create novel therapeutics tailored for specific biological ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...